- Home
- MERC vs MREO Comparison
MERC vs MREO Comparison
Compare MERC & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MERC
- MREO
- Stock Information
- Founded
- MERC 1968
- MREO 2015
- Country
- MERC Canada
- MREO United Kingdom
- Employees
- MERC N/A
- MREO N/A
- Industry
- MERC Paper
- MREO Biotechnology: Pharmaceutical Preparations
- Sector
- MERC Basic Materials
- MREO Health Care
- Exchange
- MERC Nasdaq
- MREO Nasdaq
- Market Cap
- MERC 271.5M
- MREO 281.6M
- IPO Year
- MERC 1987
- MREO N/A
- Fundamental
- Price
- MERC $3.05
- MREO $1.73
- Analyst Decision
- MERC Hold
- MREO Strong Buy
- Analyst Count
- MERC 3
- MREO 5
- Target Price
- MERC $4.67
- MREO $7.40
- AVG Volume (30 Days)
- MERC 484.3K
- MREO 910.9K
- Earning Date
- MERC 10-30-2025
- MREO 11-11-2025
- Dividend Yield
- MERC 9.74%
- MREO N/A
- EPS Growth
- MERC N/A
- MREO N/A
- EPS
- MERC N/A
- MREO N/A
- Revenue
- MERC $1,951,044,000.00
- MREO $500,000.00
- Revenue This Year
- MERC N/A
- MREO N/A
- Revenue Next Year
- MERC $13.33
- MREO $55.50
- P/E Ratio
- MERC N/A
- MREO N/A
- Revenue Growth
- MERC N/A
- MREO N/A
- 52 Week Low
- MERC $2.59
- MREO $1.47
- 52 Week High
- MERC $8.28
- MREO $4.72
- Technical
- Relative Strength Index (RSI)
- MERC 42.99
- MREO 45.94
- Support Level
- MERC $3.07
- MREO $1.68
- Resistance Level
- MERC $3.29
- MREO $1.88
- Average True Range (ATR)
- MERC 0.14
- MREO 0.08
- MACD
- MERC 0.00
- MREO 0.01
- Stochastic Oscillator
- MERC 5.71
- MREO 31.82
About MERC Mercer International Inc.
Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The company has a geographical presence in the USA, Germany, China, and Other countries, where the majority of revenue is generated from the USA. The majority of the revenue is generated from the Pulp segment.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).